Skip to primary navigation Skip to main content
0 item $0.00

Professor Karlheinz Peter


Professor Karlheinz Peter

Head: Atherothrombosis and Vascular Biology

Deputy Director, Basic and Translational Science

Lead: Atherothrombosis Program


La Trobe University supervisor

Monash University supervisor

RMIT University supervisor

Torrens University supervisor

NHMRC L3 Investigator

+61 3 8532 1490

Professor Karlheinz Peter is Deputy Director (Basic and Translational Research), lead of the Atherothrombosis Program and head of the Atherothrombosis and Vascular Biology laboratory at the Baker Heart and Diabetes Institute. He is also an interventional cardiologist at the Alfred Hospital. He is Professor of Medicine and Immunology at Monash University, and holds adjunct professorial positions at La Trobe and RMIT University. Furthermore, he holds a NHMRC principal research fellowship.

Professor Peter underwent his basic science and clinical training at prestigious cardiology centres at the University of Freiburg and Heidelberg in Germany. He did his postdoctoral training at Johns Hopkins University, Baltimore and at Scripps Research Foundation, La Jolla, USA. Professor Peter has previously been the director of the cardiac catheter laboratory at the University of Freiburg. Although focusing on research, he continues to work part time as an interventional cardiologist at the Alfred Hospital. Professor Peter has received over 20 prestigious awards/prizes, including the central awards of the German Societies of Cardiology and Angiology as well as the Cardiac Society of Australia and New Zealand and the Australian Heart Foundation. He is editor (including chief and deputy editor) on several international basic science and clinical journals.

Professor Peter’s research is focused on the cellular mechanisms of coronary artery disease and its consequence, myocardial infarction, encompassing the role of platelets, coagulation and inflammation in atherosclerosis, particularly the mechanisms leading to the rupture of atherosclerotic plaques. He has developed novel biomarker approaches and molecular imaging strategies using MRI, ultrasound, CT and PET towards the localisation of thrombi, inflammatory reactions and vulnerable, rupture-prone plaques and the identification of patients at risk of myocardial infarction. Furthermore, he applies innovative bio- and nano-technology to develop novel therapies for cardiovascular and inflammatory diseases.


  • RT Hall Prize for outstanding achievements in cardiovascular research (2014)
  • Ross Hohnen Award for the best research application, National Heart Foundation (2012)
  • World Congress of Cardiology Fellowship Award, National Heart Foundation of Australia (2005)
  • Schwarz-Monheim-Prize of the German Society of Angiology (2000)


  • Principal Research Fellow, National Health and Medical Research Council of Australia (2014)
  • Senior Research Fellow, National Health and Medical Research Council of Australia (2009)
  • Future Fellowship of the Australian Research Council (2009)

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more